Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKinovo Plc Regulatory News (KINO)

Share Price Information for Kinovo Plc (KINO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 53.50
Bid: 52.00
Ask: 55.00
Change: -2.50 (-4.46%)
Spread: 3.00 (5.769%)
Open: 56.00
High: 55.00
Low: 53.50
Prev. Close: 56.00
KINO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8 (OPD) (Rx3 Holdings Limited)

1 Sep 2023 12:37

RNS Number : 1576L
Rx3 Holdings Limited
01 September 2023
 

FORM 8 (OPD)

 

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER

Rules 8.1 and 8.2 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

Rx3 Holdings Limited

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

Tim Scott

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Rx3 Holdings Limited

(d) Is the discloser the offeror or the offeree?

OFFEROR

(e) Date position held:

The latest practicable date prior to the disclosure

31 August 2023

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

N/A

 

2. POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

 

Class of relevant security:

 

 

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

Nil

0

Nil

0

(2) Cash-settled derivatives:

 

Nil

0

Nil

0

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

Nil

0

Nil

0

 

TOTAL:

Nil

0

Nil

0

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

(b) Rights to subscribe for new securities

 

Class of relevant security in relation to which subscription right exists:

None

Details, including nature of the rights concerned and relevant percentages:

N/A

 

 

3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

Details of any interests, short positions and rights to subscribe (including directors' and other employee options) of any person acting in concert with the party to the offer making the disclosure:

 

The ultimate beneficial owner of Rx3 Holdings Limited, Tim Scott, has, by virtue of being the ultimate beneficial owner of Tipacs2 Limited, control over the following interests in the Offeree:

 

Ordinary Shares of £0.10 each

 

Name

No. of ordinary shares of £0.10 each

Percentage of issued share capital

Tipacs2 Limited

18,574,854

29.58%

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

 

(c) Attachments

 

Are any Supplemental Forms attached?

 

Supplemental Form 8 (Open Positions)

NO

Supplemental Form 8 (SBL)

NO

 

 

Date of disclosure:

01 September 2023

Contact name:

James Edis

Telephone number:

+44 (0) 7902 709 067

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FEEFFLFBXKLXBBF
Date   Source Headline
25th Aug 20237:00 amRNSShare Incentive Plan, Director/PDMR Shareholding
25th Aug 20237:00 amRNSRule 2.9 announcement
25th Aug 20237:00 amRNSStatement regarding minimum potential offer
24th Aug 20232:14 pmRNSForm 8.3 - Kinovo plc
24th Aug 20231:00 pmRNSStatement regarding possible offer
4th Aug 20235:20 pmRNSAnnual Report and Notice of Annual General Meeting
19th Jul 20237:00 amRNSHolding(s) in Company
11th Jul 20237:00 amRNSFinal results for the year ended 31 March 2023
7th Jul 20237:00 amRNSNotice of Results & Investor Presentation
3rd Jul 20237:00 amRNSHolding(s) in Company
29th Jun 202310:58 amRNSHolding(s) in Company
22nd May 20237:00 amRNSAdditional Framework and Contracts Wins
17th May 20237:00 amRNSTrading Update
28th Feb 202312:00 pmRNSHolding(s) in Company
22nd Feb 20237:00 amRNSContract Win and NHMF Net Zero Carbon Framework
23rd Jan 20237:00 amRNSLondon Borough of Waltham Forest Contract Win
17th Jan 20237:00 amRNSHighest-ranking regional contractor awards
5th Dec 20227:00 amRNSNotice of Investor Presentation
28th Nov 20227:00 amRNSInterim Results
15th Nov 20227:00 amRNSNotice of Results
5th Oct 20227:00 amRNSRenewal of Debt Facilities
15th Sep 202212:06 pmRNSResult of AGM and Directorate change
15th Sep 20227:00 amRNSAGM Trading Update
13th Sep 202211:41 amRNSDirector/PDMR Shareholding
12th Sep 20228:18 amRNSHolding(s) in Company
26th Aug 20227:54 amRNSShare Incentive Plan purchase
23rd Aug 20222:38 pmRNSAnnual Report and Notice of Annual General Meeting
19th Aug 20222:05 pmRNSSecond Price Monitoring Extn
19th Aug 20222:00 pmRNSPrice Monitoring Extension
19th Aug 20227:00 amRNSFinal Results
28th Jul 20222:22 pmRNSHolding(s) in Company
27th Jul 20226:14 pmRNSHolding(s) in Company
27th Jul 20224:41 pmRNSSecond Price Monitoring Extn
27th Jul 20224:36 pmRNSPrice Monitoring Extension
27th Jul 20222:05 pmRNSSecond Price Monitoring Extn
27th Jul 20222:00 pmRNSPrice Monitoring Extension
15th Jul 202212:54 pmRNSHolding(s) in Company
11th Jul 20227:00 amRNSFurther update re DCB Kent Limited
25th May 20227:11 amRNSHolding(s) in Company
24th May 20225:20 pmRNSUpdate re DCB Kent Limited
17th May 20229:05 amRNSSecond Price Monitoring Extn
17th May 20229:00 amRNSPrice Monitoring Extension
16th May 20224:33 pmRNSUpdate re DCB Kent Limited ("DCB")
6th May 202211:06 amRNSSecond Price Monitoring Extn
6th May 202211:00 amRNSPrice Monitoring Extension
6th May 20227:00 amRNSYear-End Trading Update
31st Mar 20221:25 pmRNSDirectorate Change
12th Jan 20227:10 amRNSDisposal of Construction Division
7th Dec 20217:00 amRNSHalf year results
3rd Dec 202110:14 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.